Brief: I'rom Group buys 61 pct stake in CMAX Clinical Research
Dec 15 (Reuters) - I'rom Group Co Ltd 2372.T :
* Says it acquired 61 percent stake in CMAX Clinical
Research Pty Ltd from IDT Australia Limited for AU$10 million
* Says previous release disclosed on Oct. 25
Source text in Japanese: https://goo.gl/QkJFW7
Further company Coverage: 2372.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: qiujing.li.thomsonreuters.com@reuters.net))
Recent news on I'rom Co
See all newsTo Retire Treasury Shares Worth 1.89% Of Outstanding Stock On May 13
9-MTH group results
Blackstone-Backed Group To Launch Management Buyout Tender Offer For Its Shares On Feb 3 After Clearing Regulatory Process In Australia
Brief: ACCC Says Blackstone Acquisition Of Clinical Trial Service Provider Not Opposed
Brief: Australia's ACCC Says Blackstone's Proposed Acquisition Of I'Rom Raises Concerns